Eden Research PLC
EDNSF
$0.035
-$0.015-30.00%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 38.35% | 65.09% | 112.32% | 97.18% | 74.76% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 38.35% | 65.09% | 112.32% | 97.18% | 74.76% |
| Cost of Revenue | 74.95% | 82.27% | 93.05% | 71.49% | 41.96% |
| Gross Profit | 8.90% | 48.69% | 137.01% | 129.18% | 114.65% |
| SG&A Expenses | 17.93% | 25.43% | 35.14% | 25.36% | 12.17% |
| Depreciation & Amortization | -10.24% | -25.46% | -38.09% | -25.38% | -15.32% |
| Other Operating Expenses | -3.08% | -121.37% | -- | -- | -- |
| Total Operating Expenses | 31.74% | 35.33% | 40.30% | 29.95% | 15.43% |
| Operating Income | -20.38% | 0.15% | 15.84% | 20.20% | 27.10% |
| Income Before Tax | 67.48% | 69.69% | 71.75% | 7.13% | -168.49% |
| Income Tax Expenses | 36.99% | -8.25% | -75.00% | -53.27% | -25.30% |
| Earnings from Continuing Operations | 69.49% | 73.87% | 77.91% | 11.23% | -190.44% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 418.52% | 500.00% | 34.62% | -67.74% | -140.91% |
| Net Income | 69.61% | 73.96% | 77.97% | 11.17% | -191.23% |
| EBIT | -20.38% | 0.15% | 15.84% | 20.20% | 27.10% |
| EBITDA | -27.45% | -5.51% | 11.20% | 18.80% | 28.63% |
| EPS Basic | 77.78% | 80.73% | 83.41% | 16.22% | -187.50% |
| Normalized Basic EPS | 10.81% | 23.26% | 34.69% | 30.00% | 30.19% |
| EPS Diluted | 77.78% | 80.73% | 83.41% | 16.22% | -187.50% |
| Normalized Diluted EPS | 10.81% | 23.26% | 34.69% | 30.00% | 30.19% |
| Average Basic Shares Outstanding | 26.71% | 28.53% | 30.54% | 20.58% | 10.61% |
| Average Diluted Shares Outstanding | 26.71% | 28.53% | 30.54% | 20.58% | 10.61% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |